There are 25,000 Australians living with end-stage kidney disease (ESKD)*.
ESKD is a life-long condition. Patients often experience high symptom burden and poor quality of life. If a kidney transplant is not an option, patients usually undergo dialysis multiple times per week, often for many years.
This is the reality for more than 10,000 people receiving haemodialysis for ESKD in Australia*. At least six large-bore needles per week are put in their arm – 312 needle insertions per year. Needles are approximately 3mm x 25-38mm, much larger than standard needles used for taking blood.
That’s what talented researcher, Associate Professor Shilpa Jesudason, wants to change, through the INJECT Study – a research program aimed to reduce the fear of needles.
“INJECT will develop, trial and evaluate an intervention to measure and help patients manage needle fear and help nurses support patients. The project represents a major advance in addressing needle distress, empowering patients and providing support for self-management,”
Associate Professor Jesudason’s work is crucial for patients like Elias Iliopolous, a dialysis patient who deals with his needle fear every week.